These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17172737)
1. Identification of tumor antigens by using proteomics. Le Naour F Methods Mol Biol; 2007; 360():327-34. PubMed ID: 17172737 [TBL] [Abstract][Full Text] [Related]
2. An efficient proteomics-based approach for the screening of autoantibodies. Canelle L; Bousquet J; Pionneau C; Deneux L; Imam-Sghiouar N; Caron M; Joubert-Caron R J Immunol Methods; 2005 Apr; 299(1-2):77-89. PubMed ID: 15914192 [TBL] [Abstract][Full Text] [Related]
3. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA). Hamrita B; Chahed K; Kabbage M; Guillier CL; Trimeche M; Chaïeb A; Chouchane L Clin Chim Acta; 2008 Jul; 393(2):95-102. PubMed ID: 18424265 [TBL] [Abstract][Full Text] [Related]
4. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer. Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361 [TBL] [Abstract][Full Text] [Related]
5. Detection of eight antibodies in cancer patients' sera against proteins derived from the adenocarcinoma A549 cell line using proteomics-based analysis. Nakanishi T; Takeuchi T; Ueda K; Murao H; Shimizu A J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 838(1):15-20. PubMed ID: 16707281 [TBL] [Abstract][Full Text] [Related]
6. A proteomic approach based on multiple parallel separation for the unambiguous identification of an antibody cognate antigen. Mun J; Kim YH; Yu J; Bae J; Noh DY; Yu MH; Lee C Electrophoresis; 2010 Oct; 31(20):3428-36. PubMed ID: 20872419 [TBL] [Abstract][Full Text] [Related]
7. Alpha 1-antitrypsin: a novel tumor-associated antigen identified in patients with early-stage breast cancer. López-Árias E; Aguilar-Lemarroy A; Felipe Jave-Suárez L; Morgan-Villela G; Mariscal-Ramírez I; Martínez-Velázquez M; Alvarez AH; Gutiérrez-Ortega A; Hernández-Gutiérrez R Electrophoresis; 2012 Jul; 33(14):2130-7. PubMed ID: 22821488 [TBL] [Abstract][Full Text] [Related]
8. Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. Yang F; Xiao ZQ; Zhang XZ; Li C; Zhang PF; Li MY; Chen Y; Zhu GQ; Sun Y; Liu YF; Chen ZC J Proteome Res; 2007 Feb; 6(2):751-8. PubMed ID: 17269731 [TBL] [Abstract][Full Text] [Related]
9. Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. Lu H; Goodell V; Disis ML J Proteome Res; 2008 Apr; 7(4):1388-94. PubMed ID: 18311901 [TBL] [Abstract][Full Text] [Related]
10. [Comparison of proteomic strategies to identify antibodies resulting from the humoral immune response to cancer]. Desmetz C; Mangé A; Solassol J Med Sci (Paris); 2008 Dec; 24(12):1071-6. PubMed ID: 19116117 [TBL] [Abstract][Full Text] [Related]
11. Identification of leukemia-associated antigens in chronic myeloid leukemia by proteomic analysis. Zou L; Wu Y; Pei L; Zhong D; Gen M; Zhao T; Wu J; Ni B; Mou Z; Han J; Chen Y; Zhi Y Leuk Res; 2005 Dec; 29(12):1387-91. PubMed ID: 15936817 [TBL] [Abstract][Full Text] [Related]
12. Identification of tumor-associated antigens using proteomics. Naour FL; Brichory F; Beretta L; Hanash SM Technol Cancer Res Treat; 2002 Aug; 1(4):257-62. PubMed ID: 12625784 [TBL] [Abstract][Full Text] [Related]
13. Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma. Fujita Y; Nakanishi T; Hiramatsu M; Mabuchi H; Miyamoto Y; Miyamoto A; Shimizu A; Tanigawa N Clin Cancer Res; 2006 Nov; 12(21):6415-20. PubMed ID: 17085654 [TBL] [Abstract][Full Text] [Related]
14. Autoantibody to tumor antigen, alpha 2-HS glycoprotein: a novel biomarker of breast cancer screening and diagnosis. Yi JK; Chang JW; Han W; Lee JW; Ko E; Kim DH; Bae JY; Yu J; Lee C; Yu MH; Noh DY Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1357-64. PubMed ID: 19423516 [TBL] [Abstract][Full Text] [Related]
15. Detection of autoantibodies against cyclophilin A and triosephosphate isomerase in sera from breast cancer patients by proteomic analysis. Tamesa MS; Kuramitsu Y; Fujimoto M; Maeda N; Nagashima Y; Tanaka T; Yamamoto S; Oka M; Nakamura K Electrophoresis; 2009 Jun; 30(12):2168-81. PubMed ID: 19582718 [TBL] [Abstract][Full Text] [Related]
16. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Fujita Y; Nakanishi T; Miyamoto Y; Hiramatsu M; Mabuchi H; Miyamoto A; Shimizu A; Takubo T; Tanigawa N Cancer Lett; 2008 May; 263(2):280-90. PubMed ID: 18334280 [TBL] [Abstract][Full Text] [Related]
17. A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins. Canelle L; Bousquet J; Pionneau C; Hardouin J; Choquet-Kastylevsky G; Joubert-Caron R; Caron M Electrophoresis; 2006 Apr; 27(8):1609-16. PubMed ID: 16550497 [TBL] [Abstract][Full Text] [Related]
18. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. Desmetz C; Bibeau F; Boissière F; Bellet V; Rouanet P; Maudelonde T; Mangé A; Solassol J J Proteome Res; 2008 Sep; 7(9):3830-7. PubMed ID: 18683965 [TBL] [Abstract][Full Text] [Related]
19. A proteomics approach to find a new breast cancer-specific antigenic marker. Kobayashi R Clin Cancer Res; 2001 Nov; 7(11):3325-7. PubMed ID: 11705843 [No Abstract] [Full Text] [Related]
20. Immunoproteomics to identify tumor-associated antigens eliciting humoral response. Mou Z; He Y; Wu Y Cancer Lett; 2009 Jun; 278(2):123-129. PubMed ID: 18930343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]